Status:
COMPLETED
Dexmedetomidine Compared to Ketofol for Sedation in Paediatrics
Lead Sponsor:
Ain Shams University
Conditions:
Vital Signs
Eligibility:
All Genders
5-10 years
Phase:
PHASE1
Brief Summary
Dental fear and anxiety remain common problems that should be managed by both the dentist and the anesthetist. The currently available evidence for safe and effective sedative drugs for children under...
Detailed Description
This double-blind, parallel-group, randomized clinical study will recruiter anxious children who will undergo dental pulp therapy. The study participants will be allocated into two equal groups. Subje...
Eligibility Criteria
Inclusion
- ASA-I children,
- aged 5-10 years-old,
- requiring dental pulp therapy
Exclusion
- ASA class ≥ II;
- previous experience with GA or Conscious sedation (CS);
- dental treatment expected to exceed 45 minutes;
- history of allergy to local anesthetics, Dex, propofol, ketamine, eggs, or soya;
- respiratory tract infections
Key Trial Info
Start Date :
October 10 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04678050
Start Date
October 10 2020
End Date
December 30 2021
Last Update
August 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams University
Cairo, Abassia, Egypt